Kinaxis stock stood at CAD 175.74 as SaaS growth reached 20 percent

Published on 10/08/2026 at 07:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Kinaxis stock posted Q2 SaaS revenue of USD 106.5 million, up 20 percent year over year. Full-year revenue guidance stands at USD 625 million to USD 640 million.

KXS, CA49448Q1090, Illustration mit AI erstellt.

Kinaxis stock (ISIN CA49448Q1090) was last at CAD 175.74 on the Toronto Stock Exchange on October 7, 2026, at 4:00 p.m. ET, with a 0.88 percent daily gain. The price report comes as the company moves deeper into an AI-led supply chain software transition, with Q2 SaaS revenue up 20 percent year over year to USD 106.5 million, according to ScanX News.

Q2 growth shifts toward SaaS

Kinaxis generated USD 158.8 million of total revenue in Q2 2026, a 16 percent year-over-year increase. SaaS accounted for USD 106.5 million, or 67 percent of total revenue, compared with 65 percent in the prior-year period, according to ScanX News.

Adjusted EBITDA reached USD 41.4 million, up 23 percent, with a 26 percent margin. Net profit rose 15 percent to USD 21.2 million, while operating cash flow increased 36 percent to USD 30.7 million in the quarter, the same report said.

Guidance raises the execution bar

Management lifted 2026 total revenue guidance to USD 625 million to USD 640 million, implying 14 percent to 17 percent growth, and set SaaS growth guidance at 18 percent to 20 percent. Adjusted EBITDA margin guidance remains 25 percent to 26 percent, according to ScanX News.

The key tension is visible in the mix: recurring SaaS revenue is expanding, while maintenance revenue declined 20 percent to USD 4.4 million during the quarter. Foreign exchange headwinds are expected to reduce full-year revenue by USD 4 million to USD 4.5 million, creating a measurable counterweight to the raised outlook.

Analysts see room above CAD 175.74

MarketBeat lists seven analysts with a Buy consensus and an average price target of CAD 203.12. That target lies 15.6 percent above the CAD 175.74 reference price, while the stock sits 6.0 percent below its 52-week high of CAD 186.98.

The same MarketBeat page identifies National Bank Financial raising its target from CAD 200.00 to CAD 210.00 and BMO Capital Markets lifting its target from CAD 195.00 to CAD 200.00, both with outperform ratings on August 7, 2026. The figures frame execution against the raised guidance as the central valuation test.

Kinaxis stock stays below its yearly high

Kinaxis stock was last at CAD 175.74 on October 7, 2026, on the Toronto Stock Exchange, with a 52-week range of CAD 117.22 to CAD 186.98 and a market capitalization of CAD 4.8 billion. The company will hold Kinexions EMEA 2026 from October 26, 2026, according to Kinaxis.